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ABSTRACT: Hippocampus oxidative stress is considered pathogenic in neurodegenerative diseases, such as Alzheimer
disease (AD), and in neurodevelopmental disorders, such as Angelman syndrome (AS). Yet clinical benefits of antioxi-
dant treatment for these diseases remain unclear because conventional imaging methods are unable to guide manage-
ment of therapies in specific hippocampus subfields in vivo that underlie abnormal behavior. Excessive production of
paramagnetic free radicals innonhippocampusbrain tissue canbemeasured in vivo as a greater-than-normal 1/T1 that is
quenchable with antioxidant as measured by quench-assisted (Quest) MRI. Here, we further test this approach in
phantoms, and we present proof-of-concept data in models of AD-like and AS hippocampus oxidative stress that also
exhibit impaired spatial learning and memory. AD-like models showed an abnormal gradient along the CA1 dorsal–
ventral axis of excessive free radical production asmeasured byQuestMRI, and redox-sensitive calcium dysregulation
asmeasuredbymanganese-enhancedMRI and electrophysiology. In theASmodel, abnormally high free radical levels
were observed in dorsal and ventral CA1. Quest MRI is a promising in vivo paradigm for bridging brain sub-
field oxidative stress and behavior in animal models and in human patients to better manage antioxidant therapy in
devastating neurodegenerative and neurodevelopmental diseases.—Berkowitz, B. A., Lenning, J., Khetarpal, N., Tran,
C., Wu, J. Y., Berri, A. M., Dernay, K., Haacke, E. M., Shafie-Khorassani, F., Podolsky, R. H., Gant, J. C., Maimaiti, S.,
Thibault, O., Murphy, G. G., Bennett, B. M., Roberts, R. In vivo imaging of prodromal hippocampus CA1 subfield
oxidativestress inmodelsofAlzheimerdiseaseandAngelmansyndrome.FASEBJ.31,4179–4186(2017).www.fasebj.org
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In neurodegenerative diseases, such as Alzheimer disease
(AD), and in neurodevelopmental disorders, such as
Angelman syndrome (AS), patients demonstrate impair-
ment in goal location based on surrounding landmarks
(i.e., allocentric spatial disorientation) as one of many
debilitating morbidities (1, 2). An essential brain region
involved in encoding spatial memories is the CA1 subfield
of the mid- and posterior hippocampus (human) or dorsal
CA1 (CA1d) in rodents (3, 4). A leading hypothesis in the
field based on ex vivomeasurements is that hippocampus
oxidative stress plays a pathogenic role in spatial disori-
entation (2, 5–16). This hypothesis has developed on the
basis of studies in postmortem tissue of oxidative damage
biomarkers, such as buildup of the polyunsaturated fatty
acid oxidation product 4-hydroxynonenal (HNE) (17, 18).
At present, it is not possible to measure excessive pro-
duction of free radicals from hippocampus CA1 subfields
in vivo. Thus, translation of basic science findings into
personalized management of antioxidant treatments in
patients has been limited andamajorproblem for clinically
testing and improving therapeutic efficacy.
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Quench-assisted (Quest) MRI has recently been sug-
gested asa robust andsensitive tool formappingexcessive
free radical production in different layers of the retina in
vivowithout a contrast agent (15, 19). TheQuestMRI index
of abnormally high production of paramagnetic free rad-
icals is a greater-than-normal spin-lattice relaxation rate
R1 (1/T1) that can be returned to baseline after acute anti-
oxidantadministration (15, 19, 20).Ourpreliminarystudies
find agreement between Quest MRI in vivo and reference
standard free radical measurements in several animal
models (15, 19). For example, in amousemodel of diabetic
retinopathy, and in pharmaceutical and genetic models of
outer retinaldegeneration,QuestMRI,histochemical stains
such as dichlorofluorescein and dihydroethidine, and a
bioluminescence method such as lucigenin, all identify the
outer retina as the first location to show evidence of oxi-
dative stress before overt histopathology is apparent (15,
19, 21, 22). However, more work is needed in phantoms to
directly confirm that sustained free radical production per
se is what Quest MRI detects. Also, it is unclear whether
Quest MRI can be applied to study nonretinal brain tissue,
such as hippocampal CA1 subfields.
In this study, we tested the feasibility of using Quest
MRI toprovideevidenceof localizedoxidativestress invivo
in brain subfields identified fromprevious ex vivo studies in
animal models that exhibit spatial disorientation. We
evaluated Quest MRI during sustained superoxide pro-
duction from the xanthine/xanthine oxidase reaction
(23, 24).We provide proof-of-concept data that QuestMRI
canbeapplied to evaluatehippocampus subfields in vivo in
3 disease models: aldehyde dehydrogenase 2-knockout
mice, 5xFAD mice, and UBE3A-knockout mice (25–29).
Aldehyde dehydrogenase 2mice are also calledHNEmice
because they exhibit a greater-than-normal hippocam-
pus concentration of the peroxidation product HNE (the
earliest evidence for oxidative stress in patients with
prodromal AD (30), together with spatial learning and
memory impairments and age-dependent spontaneous
AD-like histopathology (17). 5xFAD mice are a common
b-amyloidogenic model of familial AD that demonstrates
hippocampus oxidative stress (including HNE accumula-
tion) and spatial cognitive defects (26, 28).UBE3A-knockout
mice are a model of AS, a genetic neurodevelopmental
disorder characterized by hippocampus oxidative stress
and impaired goal location based on external cues and
other endophenotypes consistentwith that in patientswith
AS (2, 31). Because oxidative stress impairs L-type calcium
channel (LTCC) function and afterhyperpolarization
(AHP; due to reduced calcium entry) (32–36), we also ex-
amined 5xFADmice for downstream functional oxidative
damage produced by excessive free radical production.
LTCC function was measured in vivo along the dorsal–
ventral CA1 axis using manganese-enhanced MRI
(MEMRI) (37); calcium-dependent AHP in the dorsal hip-
pocampus CA1 subfield was also evaluated (35, 36).
MATERIALS AND METHODS
All animalswere treated in accordancewith theGuide for the Care
and Use of Laboratory Animals (National Institutes of Health
(Bethesda, MD, USA), the Statement for the Use of Animals in
Ophthalmic and Vision Research (Association for Research in Vi-
sion and Ophthalmology, Rockville, MD, USA), and the In-
stitutional Animal and Care Use Committee authorization
(Wayne State University, University of Michigan, and the Uni-
versity of Kentucky). Animals were housed and maintained in
12:12-h light–dark cycle laboratory lighting, unless otherwise
noted.
Experiments
In vitro study
Xanthine/xanthine oxidase is a commonly used system to con-
tinuously generate superoxide free radicals in vitro (23, 38). Phan-
toms used for this study consisted of a 0.7-mlmicrocentrifuge tube
containingeitherxanthineoxidase (0.135U/ml, 150ml) orxanthine
oxidase (0.135 U/ml, 150 ml) with either superoxide dismutase
(SOD; 125 U/ml, 60 ml) or additional PBS (60 ml). After collecting
baseline scans, xanthine (2.9 mM, 300 ml) was carefully added to
the reaction vessel inside the magnet via PE20 tubing, and 1/T1
measurements were obtained. Preliminary experiments were
performed to confirm continuous production of free radicals over
the examination period based on absorbance spectroscopy (data
not shown). All reagents were purchased from Sigma-Aldrich (St.
Louis, MO, USA), and all stock solutions were prepared in PBS.
Animal models
Three-month-old HNE mice (17), 2-mo-old 5xFAD mice, and
4-mo-old AS mice [all on C57BL/6 (B6) backgrounds] were
studied; additional age-matched B6 mice were purchased as
needed (The Jackson Laboratory, Bar Harbor, ME, USA). In all
cases, a baseline T1 data set was collected andmicewere allowed
to recover from the isoflurane anesthesia. Thirty minutes after
recovery, mice were treated with 1 mg/kg methylene blue (MB,
i.p., dissolved in saline); MB is an alternate electron transporter
that effectively suppresses superoxide generation from a variety
of sources (39). The next day, ;1 h before the second MRI ex-
amination, each MB-treated mouse was treated with 50 mg/kg
a-lipoic acid (ALA, i.p., dissolved in saline and pH adjusted to
;7.4). ALA is a potent free radical neutralizer (15, 19, 40). Mice
were then reanesthetizedwith isoflurane, and anotherT1 data set
was obtained from the same brain slice. All micewere humanely
killed after the second MRI examination. Some of the same
5xFADmice were allowed to recover and were then studied by
electrophysiology. A different set of 6-mo-old 5xFAD mice and
age-matched controls were separately studied using MEMRI.
MRI
Thegeneralmousepreparation forhigh resolution2-dimensional
(2-D)MRI is well established in our laboratory (15, 19, 41). HNE,
5xFAD, and AS mice were anesthetized with isoflurane (3% in-
duction, 1.2% maintenance) to allow for recovery. 5xFAD mice
studied using MEMRI were anesthetized with urethane (36%
solution i.p.; 0.083 ml/20 g animal weight, prepared fresh daily;
Sigma-Aldrich). MEMRI examination of 5xFADmice required a
prior bolus injection of MnCl2 (66 mg MnCl2·4H2O/kg, i.p.) on
the right side of awake mice (42). Four hours after this injection,
micewereanesthetizedandT1 data obtained. In terminal studies,
mice were humanely euthanized as detailed in our Division of
Laboratory Animal Resources-approved protocol.
High-resolution T1 2-D data sets were acquired on a 7 T sys-
tem (Bruker ClinScan; Bruker Daltonics, Bremen, Germany). For
the brain studies, a receive-only 4-element phased array coil was
used. In all cases, several spin-echo imageswere collected (single
transverse slice, echo time (TE) 11 ms, 12 3 12 mm
2, matrix size
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1923192, slice thickness400mm, turbofactor4). For thephantom
studies, a receive-only surface coil (1.0 cm diameter) was used,
and 3 baseline T1 data sets were first collected, followed by 5
additional T1 data sets after in-magnet addition of xanthine
starting at 2 min 40 s after injection, and then at 4 min 30 s, 7 min
20 s, 10 min 20 s, and 15 min 20 s after injection.
Because the Quest MRI experiment is looking for differences
in 1/T1 betweenbaseline andantioxidant treatment, generatinga
precise measure of 1/T1 is the major requirement. Thus, any
sequence that produces precise 1/T1 measurements can be used
for Quest MRI. Here, we performed a commonly used reference
standard saturation recovery approach in which multiple repe-
tition times (TRs) are used to preciselymeasure 1/T1 over a large
range of signal-to-noise conditions, a procedure routinely per-
formed in our laboratory (42–46). Imageswith differentTRswere
acquired in the following order (number of averages in paren-
theses): TR 0.15 s (6), 3.50 s (1), 1.00 s (2), 1.90 s (1), 0.35 s (4), 2.70 s
(1), 0.25 s (5), and 0.50 s (3). To compensate for reduced signal-to-
noise ratios at shorter TRs, progressively more images were col-
lected as the TR decreased. The time investment is about 45 min
per mouse: ;15 min to initially anesthetize the mouse, gently
position it in the cradle, and center it in the magnet; 10 min to
autoshim and autocoil calibrate; and;15 min to acquire the full
T1 data set. Removing the mouse from the magnet, humanely
killing the animal, and cleanup takes an additional;5 min.
Hippocampal electrophysiology (AHP)
5xFADmice that were examined by Quest MRI were then used
for electrophysiologic characterization of the CA1d AHP. Hip-
pocampal slices from mice were prepared as previously de-
scribed in detail (47, 48). Rostral portions of freshly dissected
brain hemispheres (including the hippocampus) were cut (350
mm) sequentially using a 3000 Vibratome (Thermo Fisher Scien-
tific, Waltham, MA, USA) in oxygenated low-Ca2+ artificial ce-
rebrospinal fluid (ACSF, 0.1 mM Ca2+). Slices containing dorsal
hippocampuswere thenplaced in an interface-type chamber and
maintained in oxygenated regular ACSF at 32°C for at least 2 h.
Regular ACSF contains the following (mM): NaCl (128), KCl (3),
CaCl (2), MgCl (2), glucose (10), KH2PO4 (1.25), and NaHCO3
(26). Individual slices were transferred one at a time to a micro-
scope stage (E600 FN; Nikon, Tokyo, Japan) equipped with a
recording chamber continuously perfused (2 ml/min) with oxy-
genated ACSF maintained at ;32°C (TC2Bip; Cell Micro Con-
trols,Norfolk,VA,USA). Sharp electrodes (70–90MV)wereused
to monitor membrane voltages recorded from CA1 pyramidal
neurons using an Axoclamp 2B amplifier (Molecular Devices,
Sunnyvale, CA,USA). Electrodeswere filledwith 2Mpotassium
methyl sulfate (KMeSO4) and 10 mM HEPES, pH 7.4, and were
pulled from borosilicate glass capillaries (World Precision In-
struments, Sarasota, FL, USA) on a P80 pipette puller (Sutter
Instrument, Novato, CA, USA). Responses were acquired in
current clampmode and data digitized (5 kHz) and stored to PCs
using pClamp 8 (Molecular Devices). To generate intracellular
AHPs, neurons were held at 265 mV, and a 100 ms current de-
polarizationpulsewasdelivered through theelectrode togenerate
4 Na+ action potentials. AHP amplitudes were measured at the
negative peak immediately following the depolarization pulse,
during the medium AHP, which typically lasts several 100 ms in
hippocampal pyramidal neurons, and at 800 ms after the end of
the step, during the slow AHP. For each cell recorded, 4–10 de-
polarizations were averaged to quantify the AHP. Only neurons
with input resistances .35 MV and overshooting action poten-
tials (.0 mV) were included in the analysis.
MRI data analysis
Within each T1 data set of 23 images, images acquired with the
same TR were first registered (rigid body) and then averaged to
generate a stack of 8 images. These averaged images were then
registered across TRs. The 1/T1 maps were then calculated via
fitting to a 3-parameter T1 equation {y = a + b3 [exp(2c3 TR)],
where a, b, and c are fitted parameters} on a pixel-by-pixel basis
usingRv.2.9.0 software (RFoundation for StatisticalComputing,
Vienna, Austria; http://www.r-project.org/) and scripts developed
in house.
Initial reports of QuestMRI normalized experimental data to
same-day control mice data to minimize day-to-day variations.
While effective, the approach is clearly impractical in a clinical
setting and in certain experimental models. Here, we introduce
new analysis procedure to eliminate the need for normalizing to
same-day control mice data. Because of slice bias in the 2-D data
and lowsignal-to-noise ratio, theT1 estimate ishighlydependent
on the signal intensityof theTR 150-ms imageand thus imprecise
(44). By normalizing to the shorter TR, some of the bias can be
removed giving a more accurate estimate for T1. We normal-
ized within and between groups for signal intensity differ-
ences by first applying 33 3 gaussian smoothing, performed
3 times, only on the TR 150-ms image to minimize noise and
emphasize signal. The smoothed TR 150-ms image was then
divided into the rest of the images in that T1 data set. Pre-
liminary experiments (data not shown) found that this pro-
cedureminimized the day-to-day variation in the 1/T1 profile
previously noted, abrogating the need for normalization to a
same-day group of control mice (15, 19).
In the brain studies, line regions of interest over presumptive
CA1d spanning ;12.5 pixels (;780 mm) along the pyramidal
region starting just ventral of the subiculum as assessed from
the anatomic image, and a region ventral to CA1d called in-
termediate hippocampus CA1 (CA1i) spanning ;15.5 pixels
(;969 mm) approximately midway down the pyramidal region)
were identified.Average1/T1MRIdata from left andrightCA1d
and CA1i were analyzed (15, 19).
Statistical analysis
In the phantom studies, we used a generalized estimating
equation approach to examine differences between groupswhile
appropriately accounting for correlations over time. We used a
first-order autoregressive correlation structure, with similar re-
sults obtained using an unstructured correlation matrix.
In the brain studies using Quest MRI, we only examined
CA1d andCA1i, conducting analyses separately for each region.
By limiting the number of brain regions analyzed, we sub-
stantially improved the power of hypothesis testing using the
methods presented here. While the data for each experimental
strain (i.e., HNE, AS, and 5xFAD) were obtained on different
dates with a different set of B6 controls, we used a linear mixed
model to jointly analyze all data to improve power to detect
differences. The dependent variable for these analyses was 1/T1,
and we included the following independent variables: animal
strain (B6, HNE, AS, 5xFAD), MB-ALA antioxidant treatment,
and the interaction between strain and MB-ALA antioxidant
treatment. A random effect of mousewithin strain was included
to account for measuring mice before and after MB-ALA anti-
oxidant treatment. A random effect of batch was evaluated, but
this effect was not significant using a likelihood ratio test, and
both Akaike’s information criterion and the Schwarz Bayesian
information criterion indicated that the batch random effect did
not improve the fit of themodels.As such,wedidnot include this
random effect in our analyses. We initially evaluated the statis-
tical significance of the interaction between strain and MB-ALA
antioxidant treatment, andweonly examined simple effects if the
interactionwas significant. For the test of the interaction,weused
a type I error rate of 0.1 because power is often much lower for
interactions. We used the resulting mixed effects model to esti-
mate the MB-ALA antioxidant treatment effect within each
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strain, the strain differences at baseline, and the strain differences
under MB-ALA antioxidant treatment. Two-tailed unpaired Stu-
dent t testswereperformedonMEMRIdata in each region (CA1d
or CA1i), and to look for AHP differences across transgenic and
wild-type (WT) animals. Data are presented as means6 SEM.
RESULTS
Detection of sustained production of free
radicals by Quest MRI in vitro
Superoxide free radicals inside themagnetwere generated
using a commonly used xanthine/xanthine oxidase en-
zymatic system (24). This resulted in a steady ;6% in-
crease over baseline 1/T1 values (Fig. 1). SODadded to the
reaction vessel prevented the increase in 1/T1 (24). These
results directly confirmed that continuous production of
biologically relevant free radicals are readily detectable
using Quest MRI.
Control mice demonstrated no evidence for
changes in hippocampus CA1 1/T1 in vivo with
or without antioxidants
Comparing all control B6micewith andwithoutMB-ALA
antioxidant treatment revealed no differences in 1/T1
for both CA1d (95% confidence interval, baseline:
0.65–0.68 s21 and with antioxidants: 0.65–0.69 s21) and
CA1i (95%confidence interval, baseline: 0.61–0.65 s21 and
with antioxidants: 0.62–0.66 s21).
Hippocampus CA1 excessive free radical
production measured in vivo in HNE, AD-like,
and AS models
Atbaseline,HNE, 5xFAD, andASmice all hadCA1d1/T1
that was greater than their respective age-matchedWT B6
mice (Fig. 2). After MB-ALA antioxidant administration,
1/T1 CA1d in all experimental groups were significantly
reduced toWT levels. The 1/T1 of CA1i region in HNE or
5xFAD mice was not different from controls, whereas in
the ASmice CA1i 1/T1 was supernormal and quenchable
(Fig. 2).
Hippocampus CA1 calcium dysregulation
identified in vivo in models of AD
In separate group of 5xFAD mice, a lower-than-normal
uptake of manganese was noted in CA1d but not CA1i as
measured by MEMRI (Fig. 3) (37, 49–51). We also found
subnormal CA1d calcium-dependent AHP (Fig. 3).
DISCUSSION
The results of the present xanthine/xanthine oxidase ex-
periment validate a key assumption of Quest MRI: sus-
tained production of free radicals has a net detectable
impact as an effective paramagnetic 1/T1 contrast mech-
anism in the absence of a spin trap contrast agent and
potentially confounding variables that are present in
vivo (15, 19, 20, 52, 53). It is commonly thought that
because free radicals have very short lifetimes and low
concentrations in vivo, they would have a negligible
impact on water 1/T1 (20, 52, 54–58). However, oxi-
dative stress is a condition that is defined as a sus-
tained, net production of free radicals, and the
available data clearly demonstrate robust detection via
Quest MRI under these conditions (15, 19, 20, 53). Be-
cause all species of free radicals are paramagnetic,
QuestMRI likely detects the total excessive free radical
burden of the tissue (15, 19, 52, 53). We estimate that
the xanthine oxidase generated an approximate steady
state concentration of superoxide free radicals of
;60 mM. This concentration estimate is somewhat
uncertain because of, for example, potential differ-
ences in viscosity between water and the intracellular
environment in vivo, which is expected to increase free
radical relaxivity (59) and the variable level of super-
oxide produced that depends in part on the oxygen
content of the solution and enzymatic activity of a
particular batch of xanthine oxidase (23, 38, 60). Un-
fortunately, conversion of 1/T1 to a superoxide con-
centration is also problematic because the relaxivity of
superoxide radicals is not known. Intriguingly, iso-
lated neutrophils produce an estimated total concen-
tration of superoxide of ;76 mM, although whether
this is representative of the concentration of free rad-
icals under oxidative stress conditions in vivo is, to our
knowledge, unknown (61). Nonetheless, the above
considerations suggest that Quest MRI has sufficient
sensitivity to detect an oxidative stress condition in
vivo that produces a sustained free radical level of
;60 mM. On the basis of the data in Fig. 1, it seems
likely that lower concentration levels can be detected
6
4
2
0
-2
-6 -2 2 6 10 14
Time (min)
%
 B
as
el
in
e 
1/
T1
Figure 1. Detection of sustained production of free radicals by
Quest MRI in vitro. Time course of 1/T1 from phantoms
containing xanthine oxidase (black circles, n = 3) before (left
of arrow, baseline) and after (right of arrow) in-magnet
addition of xanthine (arrow), or containing xanthine oxidase
and SOD (open squares, n = 3). Horizontal bar indicates
signiﬁcant difference range; error bars 6 SEM.
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and more work is needed to define the detection sen-
sitivity of Quest MRI in vivo.
In this study, the use of isoflurane is a potentially con-
founding factor because it is thought to have antioxidant
effects in and of itself (62–67). This claim is somewhat
controversial, however, with other studies showing a
prooxidant effect of isoflurane (62–67). The experiments
performed herein were not designed to resolve this con-
flict.Nonetheless,wenote that if isofluraneexertedamajor
anti- or pro-oxidant action, we would expect baseline
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Figure 3. Hippocampus CA1d but not CA1i exhibits impaired LTCC function in vivo, and CA1d shows AHP reductions in 5xFAD
mice compared to WT counterpart. A, B) Summary of normalized MEMRI 1/T1 (see Materials and Methods) of CA1i (A) and
CA1d (B) in B6 WT and 5xFAD mice. Numbers above bars indicate numbers of mice; error bars = SEM. C) Bar graph of mean
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Figure 2. Hippocampus CA1 subﬁelds demonstrates disease-dependent excessive production of free radicals in vivo. Representative
anatomic image illustrating position of CA1d (A) and CA1i (C) regions (white lines), and corresponding bar graph summaries (B, D).
Summary of normalized 1/T1 at baseline (B) and after treatment with antioxidants (AO) in B6 WT, HNE, 5xFAD, and AS mice.
Numbers above bars indicate numbers of mice; error bars 6 SEM; horizontal bar represents signiﬁcant difference.
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values between control and experimental CA1d andCA1i
to be similar.However, thiswas not observed. Instead,we
see some groups inwhich baselineCA1i values are similar
in control and experimental mice (AD-like mice) or ele-
vated compared to controls (AS mice). Thus, we reason
that non-isoflurane-based endogenous differences in free
radical production in CA1 subregions between controls
and experimental mice are the dominant source of sus-
tained free radical production observed.
CA1d andCA1iwere examined herein in 3models that
have previously been shown to have hippocampus oxi-
dative damage based on conventional ex vivo methods.
Twospatially closehippocampal regions,CA1dandCA1i,
were examined. These two regions are functionally dis-
tinct (4, 68). For example, they encode for different types of
memories [i.e., spatial (CA1d) vs. emotional (CA1i)] (3, 4,
69); they respond differently to ischemia–reperfusion (i.e.,
CA1d exhibits 9-fold more ischemic necrosis than CA1i)
(70); they have ;10% different total vascular areas (i.e.,
CA1d,CA1i) (71); and they experience different levels of
excitability (i.e., CA1d , CA1i) (72). Thus, the results
herein are first-time evidence supporting Quest MRI for
detecting in vivo disease-dependent production of abnor-
mally high levels of free radicals in CA1 subfields.
Supernormal production of free radicals is a necessary
but not sufficient condition of oxidative stress (15, 19). In
addition, it is helpful to provide evidence not just of oxi-
dative stress but also of downstream oxidative damage to
related physiology, such as neuronal calcium homeostasis
or excitability (32–34, 48). To this end, 5xFAD mice were
examined using MEMRI, the imaging modality of choice
for measuring neuronal LTCC function in vivo (37, 49–51,
73), andby electrophysiology (35, 36). LTCCs are a cellular
redox sensor (74). The combined findings of a net super-
normal free radical production inCA1dcompared toCA1i
(Quest MRI, Fig. 2), impaired LTCC function in CA1d
relative to CA1i (Fig. 3), and reduced calcium-dependent
AHP in CA1d (Fig. 3) supports the presence of oxidative
stress in CA1d relative to CA1i in the 5xFAD mice. The
results of this study are also in line with our previous re-
sults that foundagreementbetweenouter retinaloxidative
stress as measured by conventional methods and Quest
MRI (15, 19).
Quest MRI offers advantages compared to other im-
aging methods that report on oxidative stress in vivo (52,
55, 57, 75–79). These other methods involve exogenously
administered contrast agents that bind to free radicals
(spin traps) and/or require highly specialized equipment
(e.g., ref. 52). Thus, their potential clinical application is
likely limited because, for example, of a combination of
lack of U.S. Food and Drug Administration approval for
the contrast agent, difficulty of the contrast agent crossing
blood–brain/retina barriers, concerns about how disease
may alter contrast agent pharmacokinetics, and possible
modifications to endogenous neuronal redox signaling
due to binding of free radicals (55, 57, 75–80). However,
Quest MRI does not require injection of a contrast agent
or require specialized equipment, and Food and Drug
Administration–approved antioxidants can be used for
the confirmatory quench. Thus, Quest MRI clearly has
high potential for translating promising experimental
treatments into clinical practice to help manage the
pathogenic oxidative stress aspect of devastating neuro-
degenerative diseases in individual patients.
CONCLUSIONS
Localized overabundance of free radicals leading to re-
gionaloxidative stress isoneof the earliest abnormalities in
neurodegenerative diseases, including AD, and in neuro-
developmental disorders such as AS (2, 5–16, 21, 81–84).
However, conventional imaging biomarkers cannot non-
invasively measure region excess in free radical pro-
duction in vivo. For the first time, we show in 3 different
models proof of concept that Quest MRI is a promising
method to address this major long-standing problem.
Quest MRI has high translational potential and the po-
tential for personalized detection over time of supernor-
mal production of free radicals/antioxidant treatment
efficacy in localized regionsof thebrain in vivo. In addition,
QuestMRI appears tobeuseful formeasuring in vivobrain
region-specific biomarkers of the earliest relevant dys-
function underlying abnormal behaviors.
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